Overview
The purpose of this study is to evaluate the efficacy of sunobinop compared to placebo on alcohol consumption in subjects with alcohol use disorder.
Eligibility
Key Inclusion Criteria include:
- Male and female age ≥18 years.
- Diagnosis of moderate or severe alcohol use disorder.
- Currently seeking treatment for alcohol use disorder.
- Has 4 or more heavy drinking days (HDD) in each of the 4 weeks prior to baseline visit.
Key Exclusion Criteria include:
- Subjects that meet current DSM-5 criteria for moderate or severe substance use disorder other than alcohol and nicotine.
Other protocol-specific inclusion and exclusion criteria may apply.